A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD
Clinical trial NCT07583849 · RECRUITING
Trial details
- NCT number
- NCT07583849
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-24
- Primary completion
- 2027-09-30
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.